Coactosin-Like Protein in Breast Carcinoma: Friend or Foe?
Bei Wang,1 Limiao Zhao,1 Dandan Chen2 1Institute of Integration of Traditional Chinese and Western Medicine, the Hospital Affiliated to Jiangnan University, Wuxi, People’s Republic of China; 2Department of Education, School of Humanities, Jiangnan University, Wuxi, People’s Republic of ChinaCorrespo...
| Published in: | Journal of Inflammation Research |
|---|---|
| Main Authors: | Wang B, Zhao L, Chen D |
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2022-07-01
|
| Subjects: | |
| Online Access: | https://www.dovepress.com/coactosin-like-protein-in-breast-carcinoma-friend-or-foe-peer-reviewed-fulltext-article-JIR |
Similar Items
Coactosin-Like Protein 1 (COTL1) Could Be an Immunological and Prognostic Biomarker: From Pan-Cancer Analysis to Low-Grade Glioma Validation
by: Wang X, et al.
Published: (2024-03-01)
by: Wang X, et al.
Published: (2024-03-01)
Coactosin-Like Protein (COTL1) Promotes Glioblastoma (GBM) Growth in vitro and in vivo
by: Shao S, et al.
Published: (2020-10-01)
by: Shao S, et al.
Published: (2020-10-01)
Myoferlin contributes to invasiveness of human T-cell leukemia virus type 1-infected T cells
by: Md Abu Kawsar Sarker, et al.
Published: (2026-05-01)
by: Md Abu Kawsar Sarker, et al.
Published: (2026-05-01)
Pan-cancer exploration of PNO1: A prospective prognostic biomarker with ties to immune infiltration
by: Yinhui Qin, et al.
Published: (2024-09-01)
by: Yinhui Qin, et al.
Published: (2024-09-01)
Role of ADME genes in breast cancer prognosis: an analysis of risk scoring models based on multi-omics data
by: Jie Jin, et al.
Published: (2025-06-01)
by: Jie Jin, et al.
Published: (2025-06-01)
ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer
by: Litong Yao, et al.
Published: (2023-05-01)
by: Litong Yao, et al.
Published: (2023-05-01)
Identification of PTK2 as an adverse prognostic biomarker in breast cancer by integrated bioinformatics and experimental analyses
by: Yanru Chen, et al.
Published: (2022-12-01)
by: Yanru Chen, et al.
Published: (2022-12-01)
PRR13 expression as a prognostic biomarker in breast cancer: correlations with immune infiltration and clinical outcomes
by: Mingjing Meng, et al.
Published: (2025-03-01)
by: Mingjing Meng, et al.
Published: (2025-03-01)
Knockdown of BATF alleviates lung injury in septic neonates through transcriptional regulation of COTL1
by: Jihui Zhang, et al.
Published: (2024-11-01)
by: Jihui Zhang, et al.
Published: (2024-11-01)
Cytochrome b561 Serves as a Potential Prognostic Biomarker and Target for Breast Cancer
by: Yang X, et al.
Published: (2021-12-01)
by: Yang X, et al.
Published: (2021-12-01)
UNC93B1: a novel immune−related prognostic biomarker in breast cancer
by: Lv Tian, et al.
Published: (2025-07-01)
by: Lv Tian, et al.
Published: (2025-07-01)
YKT6 promotes breast cancer progression and is associated with poor prognosis and immune infiltration
by: Meilin Zhang, et al.
Published: (2026-04-01)
by: Meilin Zhang, et al.
Published: (2026-04-01)
Association of DBNDD1 with prognostic and immune biomarkers in invasive breast cancer
by: Xinzhu Huang, et al.
Published: (2025-02-01)
by: Xinzhu Huang, et al.
Published: (2025-02-01)
Insights into prognosis and immune infiltration of cuproptosis-related genes in breast cancer
by: Tingting Huang, et al.
Published: (2022-11-01)
by: Tingting Huang, et al.
Published: (2022-11-01)
The role of HGH1 in breast cancer prognosis: a study on immune response and cell cycle
by: Hailong Li, et al.
Published: (2024-09-01)
by: Hailong Li, et al.
Published: (2024-09-01)
EXT1 as an Independent Prognostic Biomarker in Breast Cancer: Its Correlation with Immune Infiltration and Clinicopathological Parameters
by: Amira Hossny, et al.
Published: (2024-12-01)
by: Amira Hossny, et al.
Published: (2024-12-01)
The ncRNA-Mediated Overexpression of Ferroptosis-Related Gene EMC2 Correlates With Poor Prognosis and Tumor Immune Infiltration in Breast Cancer
by: Xing Liu, et al.
Published: (2021-12-01)
by: Xing Liu, et al.
Published: (2021-12-01)
Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers
by: Limei Zhong, et al.
Published: (2020-08-01)
by: Limei Zhong, et al.
Published: (2020-08-01)
Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer
by: Shasha Tang, et al.
Published: (2023-02-01)
by: Shasha Tang, et al.
Published: (2023-02-01)
Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors
by: Ana Alcaraz-Sanabria, et al.
Published: (2020-01-01)
by: Ana Alcaraz-Sanabria, et al.
Published: (2020-01-01)
Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications
by: Maria Vittoria Dieci, et al.
Published: (2021-01-01)
by: Maria Vittoria Dieci, et al.
Published: (2021-01-01)
Expression and clinical significance of ACAA1 in hepatocellular carcinoma
by: LIANG Ziyuan, et al.
Published: (2025-04-01)
by: LIANG Ziyuan, et al.
Published: (2025-04-01)
GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis
by: Jie Zeng, et al.
Published: (2022-09-01)
by: Jie Zeng, et al.
Published: (2022-09-01)
Identification of Angiogenesis-Related Prognostic Biomarkers Associated With Immune Cell Infiltration in Breast Cancer
by: Dan Tao, et al.
Published: (2022-05-01)
by: Dan Tao, et al.
Published: (2022-05-01)
Tumor suppressor ACER1 correlates with prognosis and Immune Infiltration in head and neck squamous cell carcinoma
by: Zhixin Liu, et al.
Published: (2024-11-01)
by: Zhixin Liu, et al.
Published: (2024-11-01)
Predicting the immune microenvironment and prognosis with a anoikis - related signature in breast cancer
by: Xiuqing Lu, et al.
Published: (2023-07-01)
by: Xiuqing Lu, et al.
Published: (2023-07-01)
Low expression of NR1H3 correlates with macrophage infiltration and indicates worse survival in breast cancer
by: Jing Zhang, et al.
Published: (2023-01-01)
by: Jing Zhang, et al.
Published: (2023-01-01)
Comprehensive Analysis to Identify SPP1 as a Prognostic Biomarker in Cervical Cancer
by: Kaidi Zhao, et al.
Published: (2022-01-01)
by: Kaidi Zhao, et al.
Published: (2022-01-01)
EIF4G1 Is a Potential Prognostic Biomarker of Breast Cancer
by: Kun Li, et al.
Published: (2022-11-01)
by: Kun Li, et al.
Published: (2022-11-01)
Bioinformatics analysis of TRPV1 expression and its role in hepatocellular carcinoma prognosis
by: Vivek K. Kashyap, et al.
Published: (2026-03-01)
by: Vivek K. Kashyap, et al.
Published: (2026-03-01)
Comprehensive analysis of PTPN gene family revealing PTPN7 as a novel biomarker for immuno-hot tumors in breast cancer
by: Fengxu Wang, et al.
Published: (2022-09-01)
by: Fengxu Wang, et al.
Published: (2022-09-01)
Multi-Omics Analysis of the Oncogenic Value of Pituitary Tumor-Transforming Gene 1 (PTTG1) in Human Cancers
by: Lulu Wang, et al.
Published: (2024-02-01)
by: Lulu Wang, et al.
Published: (2024-02-01)
The Immune‐Related Gene CD48 Is a Prognostic Biomarker Associated With the Breast Cancer Tumor Microenvironment
by: Yi Zhao, et al.
Published: (2025-03-01)
by: Yi Zhao, et al.
Published: (2025-03-01)
Preliminary analysis of association of m<sup>7</sup>G methyltransferase 1 with pan-cancer prognosis and immune infiltration
by: CHENG Wenli, et al.
Published: (2024-07-01)
by: CHENG Wenli, et al.
Published: (2024-07-01)
NIPAL1 as a prognostic biomarker associated with pancreatic adenocarcinoma progression and immune infiltration
by: Youlong Zhu, et al.
Published: (2025-01-01)
by: Youlong Zhu, et al.
Published: (2025-01-01)
CHST1 as a prognostic-related biomarker in gastric cancer correlating with immune infiltration
by: Long Gui, et al.
Published: (2025-02-01)
by: Long Gui, et al.
Published: (2025-02-01)
SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer
by: Linyan Ge, et al.
Published: (2025-01-01)
by: Linyan Ge, et al.
Published: (2025-01-01)
ZFP1 is a biomarker related to poor prognosis and immunity in gastric cancer
by: Jibin Yao, et al.
Published: (2024-09-01)
by: Jibin Yao, et al.
Published: (2024-09-01)
Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management
by: Dong Yan-Ming, et al.
Published: (2024-12-01)
by: Dong Yan-Ming, et al.
Published: (2024-12-01)
Expression and clinical significance of CLDN7 and its immune-related cells in breast cancer
by: Xiaojie Fan, et al.
Published: (2024-08-01)
by: Xiaojie Fan, et al.
Published: (2024-08-01)
Similar Items
-
Coactosin-Like Protein 1 (COTL1) Could Be an Immunological and Prognostic Biomarker: From Pan-Cancer Analysis to Low-Grade Glioma Validation
by: Wang X, et al.
Published: (2024-03-01) -
Coactosin-Like Protein (COTL1) Promotes Glioblastoma (GBM) Growth in vitro and in vivo
by: Shao S, et al.
Published: (2020-10-01) -
Myoferlin contributes to invasiveness of human T-cell leukemia virus type 1-infected T cells
by: Md Abu Kawsar Sarker, et al.
Published: (2026-05-01) -
Pan-cancer exploration of PNO1: A prospective prognostic biomarker with ties to immune infiltration
by: Yinhui Qin, et al.
Published: (2024-09-01) -
Role of ADME genes in breast cancer prognosis: an analysis of risk scoring models based on multi-omics data
by: Jie Jin, et al.
Published: (2025-06-01)
